Valuation: CALYXTPAR

Market Cap 90.19M 80.95M 73.95M 67.56M 127M 8.47B 131M 892M 357M 4.52B 338M 331M 14.29B P/E 2026 *
-0.82x
P/E 2027 * -1.55x
Enterprise Value 90.19M 80.95M 73.95M 67.56M 127M 8.47B 131M 892M 357M 4.52B 338M 331M 14.29B EV / Sales 2026 *
17.4x
EV / Sales 2027 * 7.26x
Free-Float
73.66%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 08/06/2026
Chief Tech/Sci/R&D Officer 57 01/01/2014
Chief Executive Officer 63 24/02/2025
Director TitleAgeSince
Chairman 72 01/01/2001
Director/Board Member 63 01/01/2001
Chairman 82 06/08/2025
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/26 Free

Director

77,586 0.1477%
2/6/26 Free

Chief Executive Officer

77,586 0.1477%
2/6/26 Free

Director

64,748 0.1232%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.93% - - 90.19M
+2.63%-0.32%+22.75%+52.69% 257B
-3.36%+4.81%-17.34%+63.31% 157B
+1.73%-0.85%+9.29%+17.76% 162B
-4.23%+1.83%-56.84%-19.05% 61.96B
+1.31%+11.01%+23.90%+52.22% 58.73B
-0.76%+4.13%+0.84%-6.12% 55.42B
-2.05%-2.95%+4.30%+54.85% 49.18B
+1.73%-0.06%+18.49%+62.52% 49.27B
+1.00%-1.11%+23.29%+81.48% 44.96B
Average -0.20%+1.52%+3.19%+39.96% 89.6B
Weighted average by Cap. +0.26%+1.20%+5.29%+41.71%

Financials

2026 *2027 *
Net sales 5.19M 4.66M 4.26M 3.89M 7.34M 488M 7.57M 51.38M 20.57M 260M 19.5M 19.08M 823M 12.43M 11.16M 10.19M 9.31M 17.56M 1.17B 18.11M 123M 49.22M 623M 46.65M 45.65M 1.97B
Net income -66.51M -59.7M -54.54M -49.83M -93.97M -6.25B -96.92M -658M -263M -3.33B -250M -244M -10.54B -61.4M -55.12M -50.35M -46M -86.75M -5.77B -89.47M -607M -243M -3.08B -230M -226M -9.73B
Net Debt - -
Projected Income Statement - Annual - CALYXTPAR
Logo CALYXTPAR
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CALYXTPAR
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.180USD
Average target price
14.33USD
Spread / Average Target
+1,114.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CALYXTPAR
  1. Stock Market
  2. Stocks
  3. CLXT Stock